An existing cancer medication may be repurposed to treat a subset of cancers that currently lack targeted treatment options and are frequently linked to subpar outcomes, according to research. This subtype of cancer, which accounts for 15 % of all cancers, is particularly common in aggressive tumors like glioblastoma( brain tumor ) and osteosarcoma.
Existing cancer drug could be repurposed to fight certain aggressive cancers
